96 related articles for article (PubMed ID: 10971581)
1. Suitable experimental conditions are required to characterize interferon-alpha2b synthetic peptides.
Blank VC; Peña C; Roguin LP
Eur J Biochem; 2000 Sep; 267(18):5711-6. PubMed ID: 10971581
[TBL] [Abstract][Full Text] [Related]
2. Identification of a linear epitope of interferon-alpha2b recognized by neutralizing monoclonal antibodies.
Blank VC; Sterin-Prync A; Retegui L; Vidal A; Criscuolo M; Roguin LP
Eur J Biochem; 1999 Oct; 265(1):11-9. PubMed ID: 10491153
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological properties of chimeric interferon-alpha2b peptides.
Peña C; Blank VC; Marino VJ; Roguin LP
Peptides; 2005 Jul; 26(7):1144-9. PubMed ID: 15949632
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative activity of various flavonoids and related compounds: additive effect of interferon-alpha2b.
Blank VC; Poli C; Marder M; Roguin LP
Bioorg Med Chem Lett; 2004 Jan; 14(1):133-6. PubMed ID: 14684314
[TBL] [Abstract][Full Text] [Related]
5. Elimination of the free sulfhydryl group in the human serum albumin (HSA) moiety of human interferon-alpha2b and HSA fusion protein increases its stability against mechanical and thermal stresses.
Zhao HL; Xue C; Wang Y; Sun B; Yao XQ; Liu ZM
Eur J Pharm Biopharm; 2009 Jun; 72(2):405-11. PubMed ID: 19462475
[TBL] [Abstract][Full Text] [Related]
6. Antagonist peptides of human interferon-alpha2b isolated from phage display library inhibit interferon induced antiviral activity.
Tian W; Bai G; Li ZH; Yang WB
Acta Pharmacol Sin; 2006 Aug; 27(8):1044-50. PubMed ID: 16867257
[TBL] [Abstract][Full Text] [Related]
7. PEGylated interferon-alpha2b: a branched 40K polyethylene glycol derivative.
Ramon J; Saez V; Baez R; Aldana R; Hardy E
Pharm Res; 2005 Aug; 22(8):1374-86. PubMed ID: 16078148
[TBL] [Abstract][Full Text] [Related]
8. Molecular and biologic characterization of recombinant interferon-alpha2b.
Bordens R; Grossberg SE; Trotta PP; Nagabhushan TL
Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-41-S9-51. PubMed ID: 9208872
[TBL] [Abstract][Full Text] [Related]
9. Effect of pegylation on self-association of IFN-α2b.
Mohs A; Ambrogelly A; Yang X; Haverick M; Cheung JK; Narasimhan C; Shameem M
Mol Pharm; 2014 Jan; 11(1):158-63. PubMed ID: 24266549
[TBL] [Abstract][Full Text] [Related]
10. Examination of dye-protein interaction by gel-permeation chromatography.
Sereikaite J; Bumelis VA
Biomed Chromatogr; 2006 Feb; 20(2):195-9. PubMed ID: 16161178
[TBL] [Abstract][Full Text] [Related]
11. A cyclic chimeric interferon-alpha2b peptide induces apoptosis in tumor cells.
Blank VC; Peña C; Roquin LP
Cancer Biol Ther; 2007 Nov; 6(11):1787-93. PubMed ID: 18344681
[TBL] [Abstract][Full Text] [Related]
12. [Production of purified human recombinant alpha2b-interferon].
Mel'nik AI; Orlovskaia IV; Zholobak NM; Spivak NIa
Mikrobiol Z; 2012; 74(3):72-8. PubMed ID: 22830200
[TBL] [Abstract][Full Text] [Related]
13. Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation.
Hermeling S; Schellekens H; Maas C; Gebbink MF; Crommelin DJ; Jiskoot W
J Pharm Sci; 2006 May; 95(5):1084-96. PubMed ID: 16552750
[TBL] [Abstract][Full Text] [Related]
14. Purification and conformational properties of a human interferon alpha2b produced in Escherichia coli.
Beldarraín A; Cruz Y; Cruz O; Navarro M; Gil M
Biotechnol Appl Biochem; 2001 Jun; 33(3):173-82. PubMed ID: 11389671
[TBL] [Abstract][Full Text] [Related]
15. Influence of synthetic peptides, corresponding to fragments of the human alpha-2 interferon molecule, on the proliferation of lymphoblastoid cells in vitro. Growth inhibition and receptor binding.
Danilkovich A; Freze K; Romashkova J; Valujskikh A; Makarov E; Targoni O; Makarova N; Kushch A
FEBS Lett; 1995 Aug; 369(2-3):161-4. PubMed ID: 7649251
[TBL] [Abstract][Full Text] [Related]
16. STAT1, STAT3 and p38MAPK are involved in the apoptotic effect induced by a chimeric cyclic interferon-alpha2b peptide.
Blank VC; Peña C; Roguin LP
Exp Cell Res; 2010 Feb; 316(4):603-14. PubMed ID: 19945455
[TBL] [Abstract][Full Text] [Related]
17. Increasing the homogeneity, stability and activity of human serum albumin and interferon-alpha2b fusion protein by linker engineering.
Zhao HL; Yao XQ; Xue C; Wang Y; Xiong XH; Liu ZM
Protein Expr Purif; 2008 Sep; 61(1):73-7. PubMed ID: 18541441
[TBL] [Abstract][Full Text] [Related]
18. Molecular and Biological Characterization of a Prepared Recombinant Human Interferon Alpha 2b Isoform.
Shaaban R; El-Sayed WM; Samir S; El-Dabaa E
Appl Biochem Biotechnol; 2019 May; 188(1):72-86. PubMed ID: 30334171
[TBL] [Abstract][Full Text] [Related]
19. Studies on a growth-inhibitory peptide derived from alpha-fetoprotein and some analogs.
Eisele LE; Mesfin FB; Bennett JA; Andersen TT; Jacobson HI; Soldwedel H; MacColl R; Mizejewski GJ
J Pept Res; 2001 Jan; 57(1):29-38. PubMed ID: 11168886
[TBL] [Abstract][Full Text] [Related]
20. Structural and biologic characterization of pegylated recombinant IFN-alpha2b.
Grace M; Youngster S; Gitlin G; Sydor W; Xie L; Westreich L; Jacobs S; Brassard D; Bausch J; Bordens R
J Interferon Cytokine Res; 2001 Dec; 21(12):1103-15. PubMed ID: 11798469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
